Exelon Co. (EXC) Shares Bought by LPL Financial LLC

LPL Financial LLC lifted its stake in shares of Exelon Co. (NYSE:EXC) by 28.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 139,709 shares of the energy giant’s stock after purchasing an additional 31,359 shares during the quarter. LPL Financial LLC’s holdings in Exelon were worth $5,506,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in EXC. Bank of Nova Scotia Trust Co. bought a new position in shares of Exelon during the 3rd quarter worth about $102,000. NuWave Investment Management LLC bought a new position in shares of Exelon during the 4th quarter worth about $105,000. Delpha Capital Management LLC bought a new position in shares of Exelon during the 4th quarter worth about $108,000. Baker Ellis Asset Management LLC bought a new position in shares of Exelon during the 4th quarter worth about $118,000. Finally, Cerebellum GP LLC bought a new position in shares of Exelon during the 4th quarter worth about $122,000. 78.09% of the stock is currently owned by institutional investors.

Shares of Exelon stock opened at $37.71 on Friday. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.10 and a quick ratio of 0.94. The company has a market cap of $36,391.24, a PE ratio of 14.56, a price-to-earnings-growth ratio of 2.46 and a beta of 0.25. Exelon Co. has a one year low of $33.30 and a one year high of $42.67.

Exelon (NYSE:EXC) last posted its quarterly earnings data on Wednesday, February 7th. The energy giant reported $0.55 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.60 by ($0.05). The firm had revenue of $8.38 billion during the quarter, compared to analysts’ expectations of $7.66 billion. Exelon had a net margin of 11.53% and a return on equity of 8.35%. The company’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the business posted $0.44 EPS. equities research analysts forecast that Exelon Co. will post 3.06 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 9th. Shareholders of record on Thursday, February 15th were paid a $0.345 dividend. This is a positive change from Exelon’s previous quarterly dividend of $0.33. The ex-dividend date of this dividend was Wednesday, February 14th. This represents a $1.38 annualized dividend and a yield of 3.66%. Exelon’s dividend payout ratio (DPR) is 34.94%.

A number of equities analysts have recently issued reports on the stock. JPMorgan Chase & Co. cut their price objective on shares of Exelon from $42.00 to $40.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 21st. Royal Bank of Canada restated an “outperform” rating and issued a $43.00 target price on shares of Exelon in a report on Wednesday, February 14th. Zacks Investment Research upgraded shares of Exelon from a “hold” rating to a “buy” rating and set a $40.00 target price on the stock in a report on Friday, February 9th. KeyCorp lowered their target price on shares of Exelon from $45.00 to $40.00 and set an “overweight” rating on the stock in a report on Friday, February 9th. Finally, Morgan Stanley lowered their target price on shares of Exelon from $42.00 to $41.00 and set an “equal weight” rating on the stock in a report on Thursday, February 8th. One analyst has rated the stock with a sell rating, four have given a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the stock. Exelon presently has a consensus rating of “Buy” and a consensus target price of $40.91.

In other Exelon news, CEO Calvin Butler, Jr. sold 25,000 shares of the stock in a transaction dated Thursday, March 15th. The shares were sold at an average price of $37.94, for a total value of $948,500.00. Following the completion of the sale, the chief executive officer now owns 19,429 shares in the company, valued at approximately $737,136.26. The transaction was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 0.70% of the company’s stock.

WARNING: This report was posted by Ticker Report and is the property of of Ticker Report. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at https://www.tickerreport.com/banking-finance/3299788/exelon-co-exc-shares-bought-by-lpl-financial-llc.html.

About Exelon

Exelon Corporation is a utility services holding company. The Company, through its subsidiary, Exelon Generation Company, LLC (Generation), is engaged in the energy generation business. The Company, through its subsidiaries, Commonwealth Edison Company (ComEd), PECO Energy Company (PECO), Baltimore Gas and Electric Company (BGE), Pepco Holdings LLC (PHI), Potomac Electric Power Company (Pepco), Delmarva Power & Light Company (DPL) and Atlantic City Electric Company (ACE), is engaged in the energy delivery businesses.

Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Co. (NYSE:EXC).

Institutional Ownership by Quarter for Exelon (NYSE:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Heidrick & Struggles  Expected to Post Q2 2018 Earnings of $0.43 Per Share
Heidrick & Struggles Expected to Post Q2 2018 Earnings of $0.43 Per Share
TheStreet Lowers Acxiom  to C+
TheStreet Lowers Acxiom to C+
TheStreet Downgrades Gridsum  to D
TheStreet Downgrades Gridsum to D
Stifel Nicolaus Cuts Williams Pipeline Partners  Price Target to $41.00
Stifel Nicolaus Cuts Williams Pipeline Partners Price Target to $41.00
Cowen Initiates Coverage on Unum Therapeutics
Cowen Initiates Coverage on Unum Therapeutics
OneSmart International Education Group  Earns Overweight Rating from Analysts at Morgan Stanley
OneSmart International Education Group Earns Overweight Rating from Analysts at Morgan Stanley


© 2006-2018 Ticker Report. Google+.